Scientists test if common drug alters cancer Medicine's strength
NCT ID NCT07402915
Summary
This study aims to understand how a drug called itraconazole, often used to treat fungal infections, affects the levels of a new experimental cancer drug (AZD5335) in the body. It will involve about 24 people with advanced ovarian, fallopian tube, or primary peritoneal cancer who have stopped responding to standard platinum-based chemotherapy. The main goal is to measure drug interactions and safety, not to test how well the new drug treats the cancer itself.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
NOT_YET_RECRUITINGBatumi, 6010, Georgia
-
Research Site
NOT_YET_RECRUITINGTbilisi, 0114, Georgia
-
Research Site
NOT_YET_RECRUITINGTbilisi, 112, Georgia
-
Research Site
RECRUITINGDublin, D07 R2WY, Ireland
-
Research Site
RECRUITINGLisbon, 1250-068, Portugal
-
Research Site
RECRUITINGBarcelona, 08023, Spain
-
Research Site
RECRUITINGLogroño, 26006, Spain
-
Research Site
RECRUITINGMadrid, 28040, Spain
-
Research Site
RECRUITINGMadrid, 28050, Spain
Conditions
Explore the condition pages connected to this study.